CDKN2B-AS1 and adult T-cell leukemia/lymphoma: Furthermore, although the lncRNA ANRIL contributes to cell proliferation and likely to the malignant phenotype of HTLV infection, the inhibition of its downstream targets EZH1/2 by small molecules is currently a preferred treatment for ATLL [222].